Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Amici Capital Discloses 5.7% Stake In Debased Accretive Health Inc. (ACHI)

Paul Orlin and Alex Porter’s Amici Capital has recently disclosed a new position in Accretive Health Inc. (OTCMKTS:ACHI) in a 13G form filed with the Securities and Exchange Commission. According to the filing, the fund currently owns 5.56 million shares in the revenue cycle management services provider in the healthcare industry, which represent 5.7% of the company’s outstanding stock.

cheerful pharmacist chemist woman standing in pharmacy drugstore

Amici Capital, renamed from Porter Orlin in 2013, is a long/short equity hedge fund currently overseen by Paul Orlin. The New York-based hedge fund was established as Porter Management in 1976 by Alex Porter, who passed away in 2014. Alex Porter’s first fund delivered a net compounded annual return of 20% since its inception until 1993, when Paul Orlin joined the hedge fund as a partner. Eventually, Paul Orlin, who currently serves as the Chief Investment Officer and Portfolio Manager at Amici Capital, took the reins of the firm’s portfolio in 1994 and has not disappointed so far. The hedge fund generated an average return of 14% since Orlin joined the firm until 2013. Amici Capital is currently backed up by a team of 27 employees and has $2.2 billion in assets under management. According to the fund’s most recent 13F filing with the SEC, Amici Capital manages an equity portfolio worth $2.78 billion, while its top ten holdings amass 37.48% of the value.

Paul Orlin And Alex Porter
Paul Orlin And Alex Porter
Amici Capital

In the eyes of most traders, hedge funds are assumed to be underperforming, old investment tools of the past. While there are more than 8,000 funds in operation at present, Hedge fund experts at Insider Monkey look at the aristocrats of this group, around 700 funds. Contrary to popular belief Insider Monkey’s research revealed that hedge funds underperformed in recent years because of their short positions as well as the huge fees that they charge. Hedge funds managed to outperform the market on the long side of their portfolio. In fact, the 15 most popular small-cap stocks among hedge funds returned 123% since the end of August 2012 and beat the S&P 500 Index by some 66 percentage points (see more details here). This is a huge margin which is why hedge funds’ recent Accretive Health purchases is a strong indicator.

Accretive Health Inc. (OTCMKTS:ACHI) is a leading provider of services and technology for the healthcare industry and is one of the largest hospital revenue cycle management companies in the United States. The company has a clearly outlined mission of assisting its healthcare clients in strengthening their financial stability and delivering better care at more affordable costs. In order to accomplish its mission, Accretive has developed an end-to-end revenue cycle solution that is able to perform a number of functions such as patient registration, insurance and benefit verification, clinical documentation and coding, billing and follow up services. The stock of the company is down by 62% year-to-date and has recently plummeted after a takeover offer from Ascension Health, which significantly undervalued the company.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.